Human coronavirus HKU1

Human coronavirus HKU1 (HCoV-HKU1) is a species of coronavirus that infects humans, identified first in 2005 in Hong Kong. It is associated with mild to moderate upper respiratory tract infections, though it can also cause more severe lower respiratory tract infections, particularly in infants, the elderly, and immunocompromised individuals. The virus is part of the Betacoronavirus genus, which also includes other notable coronaviruses such as SARS-CoV and MERS-CoV.

Discovery

HCoV-HKU1 was discovered in January 2005 by a team of virologists at the University of Hong Kong. The discovery was made following the investigation of a hospitalized patient with pneumonia of unknown etiology. The virus was identified using a pan-viral microarray technique, which allows for the detection of known and novel viruses. The name HKU1 is derived from the institution where it was discovered.

Transmission

The exact modes of transmission of HCoV-HKU1 are not fully understood, but it is believed to spread through respiratory droplets produced when an infected person coughs or sneezes, similar to other respiratory viruses. Direct contact with an infected individual or with surfaces contaminated with the virus may also facilitate transmission.

Symptoms

Infection with HCoV-HKU1 can lead to a range of symptoms, from none at all to severe respiratory illness. Common symptoms include fever, cough, sore throat, and nasal congestion. In more severe cases, it can lead to bronchiolitis, pneumonia, and even respiratory failure, particularly in vulnerable populations.

Diagnosis

Diagnosis of HCoV-HKU1 infection is typically performed using polymerase chain reaction (PCR) tests, which detect the genetic material of the virus in respiratory specimens. Serological tests to detect antibodies against the virus can also be used to confirm past infection.

Treatment

There is no specific antiviral treatment recommended for HCoV-HKU1 infection. Management of the disease is supportive and focuses on the relief of symptoms. This may include the use of analgesics and antipyretics for fever and pain, along with adequate hydration and rest. In cases of severe respiratory illness, hospitalization and supportive care, such as oxygen therapy, may be required.

Prevention

Preventive measures for HCoV-HKU1 infection are similar to those for other respiratory viruses. These include frequent handwashing with soap and water, covering the mouth and nose with a tissue or the elbow when coughing or sneezing, avoiding close contact with sick individuals, and cleaning and disinfecting surfaces that are frequently touched.

Epidemiology

Since its discovery, HCoV-HKU1 has been identified in various parts of the world, indicating a wide geographic distribution. However, the overall prevalence and impact of the virus on public health are not well understood, partly due to the lack of specific surveillance systems for this and other human coronaviruses.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian